Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Nathalie A. Johnson
Jewish General Hospital, Montreal
5750 Côte-des-Neiges Rd
Montreal, QC H3S 1Y9
Canada
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
197
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
KEYNOTE-204: A Multicentre, Randomised, Open-Label, Phase 3 Study of Pembrolizumab
versus
Brentuximab Vedotin in Relapsed or Refractory Classical Hodgkin Lymphoma
Number of pages: 47
Posted: 12 Oct 2020
John Kuruvilla
,
Radhakrishnan Ramchandren
,
Armando Santoro
,
Ewa Paszkiewicz-Kozik
,
Robin Gasiorowski
, Nathalie A. Johnson,
Laura Maria Fogliatto
,
Iara Gonclaves
,
Jose S. R. de Oliveira
,
Valeria Buccheri
,
Guilherme Fleury Perini
,
Neta Goldschmidt
,
Iryna Kriachok
,
Michael Dickinson
,
Mieczyslaw Komarnicki
,
Andrew McDonald
,
Muhit Ozcan
,
Naohiro Sekiguchi
,
Ying Zhu
,
Akash Nahar
,
Patricia Marinello
,
Pier Luigi Zinzani
and
The KEYNOTE-204 Investigators
University of Toronto - Princess Margaret Cancer Centre, University of Tennessee, Knoxville, Humanitas University - Department of Biomedical Sciences, Maria Sklodowska-Curie National Institute of Oncology, The University of Sydney - Concord Hospital, Jewish General Hospital, Montreal, Hospital de Clinicas de Porto Alegre, Fundação Pio XII - Hospital de Câncer de Barretos, Casa de Saude Santa Marcelina, University of São Paulo (USP) - Hospital das Clínicas, Hospital Israelita Albert Einstein, Hebrew University of Jerusalem - Hadassah Medical Center, National Cancer Institute, Kiev, Peter MacCallum Cancer Centre, Szpital Kliniczny im. Przemienienia, Pretoria East Hospital, Ankara Üniversitesi Tip Fakültesi, National Hospital Organization Disaster Medical Center, Merck & Co., Inc., Merck & Co., Inc., Merck & Co., Inc., Universitaria di Bologna - Azienda Ospedaliero and Independent
Downloads
197
(393,598)
View PDF
Download
Abstract:
Hodgkin lymphoma, pembrolizumab, PD-1
Feedback